| 发明名称 |
MODULATION OF 5-HT2 RECEPTORS AS A TREATMENT FOR CARDIOVASCULAR DISEASES |
| 摘要 |
<p>The present invention provides for methods of treating and preventing muscle atrophy, cardiac hypertrophy, heart failure and/or primary pulmonary hypertension linked to a family of serotonin receptors called 5-HT2 receptors. The present invention further demonstrates that modulators of 5-HT2 receptors can inhibit or treat muscle atrophy, heart failure, cardiac hypertrophy, and/or primary pulmonary hypertension.</p> |
| 申请公布号 |
WO2005063220(A1) |
申请公布日期 |
2005.07.14 |
| 申请号 |
WO2004US42922 |
申请日期 |
2004.12.21 |
| 申请人 |
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM;MYOGEN, INC.;BUSH, ERIK;OLSON, ERIC;MELVIN, LARRY |
发明人 |
BUSH, ERIK;OLSON, ERIC;MELVIN, LARRY |
| 分类号 |
A61K31/4365;A61K31/47;A61K31/4706;A61K31/4743;A61K39/395;A61K48/00;G01N33/68;G01N33/94;A61K31/00;(IPC1-7):A61K31/00 |
主分类号 |
A61K31/4365 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
